作者
王相涵,张 哲,刘素坤
文章摘要
三维适形放疗(3D-CRT)、调强放疗(IMRT/VMAT)、立体定向体部放疗(SBRT/SABR)以及质子治疗的推行,使非小细胞肺癌(NSCLC)患者的生存期明显延长。但随之而来的问题是,胸部放疗相关心脏损伤(radiation-induced heart disease,RIHD)正逐渐成为影响长期生存和生活品质的严重并发症。NRG/RTOG 0617等大型临床研究已经证实,心脏受照剂量——尤其是V30、V40、V50及平均心脏剂量(MHD)——与NSCLC患者总生存(OS)的下降存在独立相关关系[1,2]。近年来学界的研究重心发生了明显转移:从早期把全心脏当成一个危及器官的粗放模式,已经转向关注心脏亚结构剂量-反应关系,并借助AI自动勾画、呼吸门控/深吸气屏气(DIBH)、质子治疗等手段降低心脏暴露[3,6]。本文试围绕肺癌放疗相关心脏损伤的流行病学、病理机制、剂量学预测、预防技术以及临床管理的最新进展做一次系统梳理。
文章关键词
肺癌;放射治疗;放射性心脏损伤;心脏亚结构;剂量学;深吸气屏气;质子治疗;心肿瘤学
参考文献
[1] Bradley JD,Paulus R,Komaki R,et al.Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer(RTOG 0617):a randomised,two-by-two factorial phase 3 study.Lancet Oncol.2015;16(2):187-199.PMID:25601342.PMCID:PMC4419359.
[2] Chun SG,Hu C,Choy H,et al.Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer:A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.J Clin Oncol.2017;35(1):56-62.PMID: 28034064.PMCID:PMC5455690.
[3] Kim K,Kim MM,Skoufos G,et al.FLASH Proton Radiation Therapy Mitigates Inflammatory and Fibrotic Pathways and Preserves Cardiac Function in a Preclinical Mouse Model of Radiation-Induced Heart Disease.Int J Radiat Oncol Biol Phys.2024;119(4):1234-1247. PMID:38364948.
[4] Wang K,Eblan MJ,Deal AM,et al.Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer:Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.J Clin Oncol.2017;35(13):1387-1394.PMID:28113017.PMCID:PMC5455462.
[5] Wildman VL,Qiu RLJ,Mandawat A,Luca K,Yang X,Kesarwala AH.Cardiac Substructure Dose Response after Lung Cancer Radiotherapy:A Systematic Review.Clin Lung Cancer.2026;27(3):273-296.e1.PMID:41820125.
[6] Wang J,Li X,Zhao Y,et al.Dosimetric Parameters of the Heart and Its Substructures in Predicting Cardiac Events or Survival in Lung Cancer Patients After Radiotherapy:A Systematic Review and Meta-Analysis.Int J Radiat Oncol Biol Phys.2026.
[7] Duane F,Aznar MC,Bartlett F,et al.A cardiac contouring atlas for radiotherapy.Radiother Oncol.2017;122(3):416-422.PMID:28233564. PMCID:PMC5356506..
[8] Lyon AR,López-Fernández T,Couch LS,et al.;ESC Scientific Document Group.2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association(EHA),the European Society for Therapeutic Radiology and Oncology(ESTRO) and the International Cardio-Oncology Society(IC-OS).Eur Heart J.2022;43(41):4229-4361.PMID:36017568.
[9] Atkins KM,Rawal B,Chaunzwa TL,et al.Cardiac Radiation Dose,Cardiac Disease,and Mortality in Patients With Lung Cancer.J Am Coll Cardiol.2019;73(23):2976-2987.
Full Text:
DOI